Somatostatin Receptor Positive
4 clinical trials · Condition
◉ Watch Somatostatin Receptor Positive
| Record | Firm | Date |
|---|---|---|
| Radioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endocrine Cancers (NCT04106843) | M.D. Anderson Cancer Center | 2019-06-13 |
Track Somatostatin Receptor Positive automatically
Every clearance here is in the API, with alerts when new ones post.